Medifast
MED
112 hedge funds and large institutions have $87.6M invested in Medifast in 2026 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 33 reducing their positions, and 20 closing their positions.
2,951% more call options, than puts
Call options by funds: $22.7M | Put options by funds: $744K
30% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 20
4.88% more ownership
Funds ownership: 73.38% → 78.27% (+4.9%)
3% more funds holding
Funds holding: 109 → 112 (+3)
1% more capital invested
Capital invested by funds: $86.5M → $87.6M (+$1.13M)
0% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 33
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCP
Steamboat Capital Partners
Rye,
New York
|
+$4.65M |
| 2 |
Two Sigma Investments
New York
|
+$2.78M |
| 3 |
Jane Street
New York
|
+$1.36M |
| 4 |
PLC
Peapod Lane Capital
Bedford Hills,
New York
|
+$1.27M |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
+$980K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.68M |
| 2 |
Lido Advisors
Los Angeles,
California
|
-$1.59M |
| 3 |
Charles Schwab
San Francisco,
California
|
-$1.57M |
| 4 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
-$1.19M |
| 5 |
D.E. Shaw & Co
New York
|
-$631K |
MED Hedge Fund Activity: Q1 2026 in Review
112 of the 8,187 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q1 2026, worth a combined $87.6M — up 1.3% from $86.5M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new MED positions and 20 closed out — a net gain of 6 holders — while 33 added to existing stakes and 33 trimmed.
The largest buyer was Steamboat Capital Partners, adding an estimated $4.65M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $1.68M sold.
- 112 institutional investors held Medifast (MED) as of Q1 2026, up from 109 in Q4 2025.
- Funds reported $87.6M of Medifast stock for Q1 2026, up 1.3% quarter-over-quarter.
- 26 funds opened new Medifast positions in Q1 2026 and 20 closed out, a net change of +6 holders.
- The largest Medifast buyer in Q1 2026 was Steamboat Capital Partners, an estimated $4.65M added.
- The largest Medifast seller in Q1 2026 was Acadian Asset Management, an estimated $1.68M sold.
Based on aggregated 13F filings for Q1 2026.